Denali Therapeutics (DNLI) Cash from Financing Activities (2017 - 2026)
Denali Therapeutics (DNLI) reported Cash from Financing Activities of $219.0 million for Q1 2026, up 5922.54% year-over-year from $3.6 million in Q1 2025, and up 14.01% on a QoQ basis from $192.1 million in Q4 2025.
Denali Therapeutics (DNLI) has 10 years of Cash from Financing Activities data on file, last reported at $219.0 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 5922.54% year-over-year to $219.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $412.0 million (up 2187.98% YoY) and the FY2025 annual result came in at $189.2 million, down 60.93% from the prior year.
- Cash from Financing Activities rose to $219.0 million in Q1 2026 per DNLI's latest filing, from $192.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $500.3 million in Q1 2024 and bottomed at -$18.6 million in Q3 2024.
- The 5-year median for Cash from Financing Activities is $4.4 million (2022), against an average of $71.8 million.
- Peak annual rise in Cash from Financing Activities reached 31089.21% in 2024, while the deepest fall reached 844.74% in 2024.
- Tracing DNLI's Cash from Financing Activities over 5 years: stood at $299.7 million in 2022, then sank by 98.43% to $4.7 million in 2023, then tumbled by 188.59% to -$4.2 million in 2024, then surged by 4709.72% to $192.1 million in 2025, then climbed by 14.01% to $219.0 million in 2026.
- Per Business Quant, the three latest DNLI Cash from Financing Activities figures stand at $219.0 million (Q1 2026), $192.1 million (Q4 2025), and -$778000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | 219.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 219.04 Mn |
| Mar 31, 2026 | 219.04 Mn |
| Dec 31, 2025 | 192.13 Mn |
| Dec 31, 2025 | 192.13 Mn |
| Sep 30, 2025 | -778,000.00 |
| Sep 30, 2025 | -778,000.00 |
| Jun 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | -3.76 Mn |
| Mar 31, 2025 | -3.76 Mn |
| Dec 31, 2024 | -4.17 Mn |
| Dec 31, 2024 | -4.17 Mn |
| Sep 30, 2024 | -18.56 Mn |
| Sep 30, 2024 | -18.56 Mn |
| Jun 30, 2024 | 6.76 Mn |
| Jun 30, 2024 | 6.76 Mn |
| Mar 31, 2024 | 500.28 Mn |
| Mar 31, 2024 | 500.28 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 2.49 Mn |
| Sep 30, 2023 | 2.49 Mn |
| Jun 30, 2023 | 9.02 Mn |
| Jun 30, 2023 | 9.02 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 299.65 Mn |
| Dec 31, 2022 | 299.65 Mn |
| Sep 30, 2022 | 5.15 Mn |
| Sep 30, 2022 | 5.15 Mn |
| Jun 30, 2022 | 4.40 Mn |
| Jun 30, 2022 | 4.40 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Sep 30, 2021 | 3.32 Mn |
| Sep 30, 2021 | 3.32 Mn |
| Jun 30, 2021 | 7.04 Mn |
| Jun 30, 2021 | 7.04 Mn |
| Mar 31, 2021 | 3.82 Mn |
| Mar 31, 2021 | 3.82 Mn |
| Dec 31, 2020 | 9.52 Mn |
| Dec 31, 2020 | 9.52 Mn |
| Sep 30, 2020 | 425.90 Mn |
| Sep 30, 2020 | 425.90 Mn |
| Jun 30, 2020 | 3.42 Mn |
| Jun 30, 2020 | 3.42 Mn |
| Mar 31, 2020 | 195.91 Mn |
| Mar 31, 2020 | 195.91 Mn |
| Sep 30, 2019 | 4.16 Mn |
| Sep 30, 2019 | 4.16 Mn |
| Jun 30, 2019 | 2.57 Mn |
| Jun 30, 2019 | 2.57 Mn |
| Mar 31, 2019 | 908,000.00 |
| Mar 31, 2019 | 908,000.00 |
| Dec 31, 2018 | 1.69 Mn |
| Dec 31, 2018 | 1.69 Mn |
| Sep 30, 2018 | 658,000.00 |
| Sep 30, 2018 | 658,000.00 |
| Jun 30, 2018 | 1.43 Mn |
| Jun 30, 2018 | 1.43 Mn |
| Mar 31, 2018 | 93.24 Mn |
| Mar 31, 2018 | 93.24 Mn |
| Dec 31, 2017 | 295.59 Mn |
| Dec 31, 2017 | 295.59 Mn |
| Sep 30, 2017 | 357,000.00 |
| Sep 30, 2017 | 357,000.00 |
| Jun 30, 2017 | 51,000.00 |
| Jun 30, 2017 | 51,000.00 |
| Mar 31, 2017 | 324,000.00 |
| Mar 31, 2017 | 324,000.00 |